Market News

Latest financial and economic news and analysis

Zacks Investment Research News Agency
6 days agoZacks Investment Research
Stocks Medium Importance Neutral
Should You Invest in the ALPS Electrification Infrastructure ETF (ELFY)?

Should You Invest in the ALPS Electrification Infrastructure ETF (ELFY)?

Designed to provide broad exposure to the Utilities - Infrastructure segment of the equity market, the ALPS Electrification Infrastructure ETF (ELFY) is a passively managed exchange traded fund launched on April 9, 2025.

Related Symbols 1
ELFY ELFY
Source: Zacks Investment Research
Visit Source
Comment
Zacks Investment Research News Agency
6 days agoZacks Investment Research
Stocks Medium Importance Neutral
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?

Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?

The First Trust Small Cap Core AlphaDEX ETF (FYX) was launched on May 8, 2007, and is a passively managed exchange traded fund designed to offer broad exposure to the Small Cap Blend segment of the US equity market.

Related Symbols 1
FYX FYX
Source: Zacks Investment Research
Visit Source
Comment
Zacks Investment Research News Agency
6 days agoZacks Investment Research
Stocks Medium Importance Neutral
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?

Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?

Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the JPMorgan Diversified Return U.S. Equity ETF (JPUS), a passively managed exchange traded fund launched on September 29, 2015.

Related Symbols 1
JPUS JPUS
Source: Zacks Investment Research
Visit Source
Comment
Zacks Investment Research News Agency
6 days agoZacks Investment Research
Stocks Medium Importance Neutral
Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now?

Is Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) a Strong ETF Right Now?

Designed to provide broad exposure to the Style Box - Mid Cap Blend category of the market, the Franklin U.S. Mid Cap Multifactor Index ETF (FLQM) is a smart beta exchange traded fund launched on 04/26/2017.

Related Symbols 1
FLQM FLQM
Source: Zacks Investment Research
Visit Source
Comment
Seeking Alpha News Agency
6 days agoSeeking Alpha
Stocks Medium Importance Neutral
Viper Energy: More Acquisitions

Viper Energy: More Acquisitions

Viper Energy, Inc. has completed several acquisitions. The latest was Riverbend. Recent deals, including the Riverbend acquisition, were likely negotiated before the sharp rise in commodity prices. VNOM's acquisition-driven growth is well-timed for a 'higher for longer' commodity price environment.

Related Symbols 1
VNOM VNOM
Source: Seeking Alpha
Visit Source
Comment
24/7 Wall Street News Agency
6 days ago24/7 Wall Street
Stocks Medium Importance Neutral
Analyst: If SpaceX Delivers Even a Quarter of Elon Musk's Promised Compute, Nvidia Could Hit $1 Trillion in Revenue

Analyst: If SpaceX Delivers Even a Quarter of Elon Musk's Promised Compute, Nvidia Could Hit $1 Trillion in Revenue

Elon Musk used SpaceX‘s (NASDAQ:SPCX | SPCX Price Prediction) first-ever public earnings call on August 4, 2026 to commit that the company will build its AI computing platform exclusively on NVIDIA‘s (NASDAQ:NVDA) Vera Rubin architecture, and floated a tentative target of 20 gigawatts of power and cooling capacity online by the end of 2027.

Related Symbols 1
Source: 24/7 Wall Street
Visit Source
Comment
GlobeNewsWire News Agency
6 days agoGlobeNewsWire
Stocks Medium Importance Neutral
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

DEER PARK, Ill., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that the Company has licensed U.S. rights to rare disease product candidate ASN-001 (timolol topical gel) from Auson Pharmaceuticals (“Auson”). ASN-001 is under development for the treatment of proliferating superficial infantile hemangiomas.

Related Symbols 1
FRG FRG
Source: GlobeNewsWire
Visit Source
Comment
PRNewsWire News Agency
6 days agoPRNewsWire
Stocks Medium Importance Neutral
Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026

Company to host conference call and webcast at 8:00 a.m. EDT CARMIEL, Israel, Aug. 5, 2026 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and commercialization of innovative therapeutics for rare diseases with significant unmet needs, today announced that it will release its financial results for the quarter ended June 30, 2026 and provide a business update on August 12, 2026.

Related Symbols 1
PLX PLX
Source: PRNewsWire
Visit Source
Comment
Business Insider News Agency
6 days agoBusiness Insider
Stocks Medium Importance Neutral
Disney beats earnings estimates in CEO Josh D'Amaro's first full quarter

Disney beats earnings estimates in CEO Josh D'Amaro's first full quarter

Disney pleased Wall Street in its first full quarter under CEO Josh D'Amaro. Shares rose over 4% in premarket trading as the Mouse House posted mixed revenue and earnings results for the quarter ending on June 27.

Related Symbols 1
DIS DIS
Source: Business Insider
Visit Source
Comment
PRNewsWire News Agency
6 days agoPRNewsWire
Stocks Medium Importance Neutral
CMC Highlights Position as a Leading, Early-Stage Construction Solutions Provider and Unveils Long-Term Financial Targets at 2026 Investor Day

CMC Highlights Position as a Leading, Early-Stage Construction Solutions Provider and Unveils Long-Term Financial Targets at 2026 Investor Day

IRVING, Texas, Aug. 5, 2026 /PRNewswire/ -- CMC (NYSE: CMC) (the "Company") today will host its 2026 Investor Day in New York City, where members of the Company's leadership team will outline CMC's strategic vision, growth opportunities, capital allocation framework, and long-term financial targets. "Over the last several years, we have taken deliberate steps to transform CMC into an industry-leading provider of solutions across the early-stage construction ecosystem.

Related Symbols 1
CMC CMC
Source: PRNewsWire
Visit Source
Comment
Zacks Investment Research News Agency
6 days agoZacks Investment Research
Stocks Medium Importance Neutral
Bull of the Day: Amkor (AMKR)

Bull of the Day: Amkor (AMKR)

Amkor Technology ( AMKR ) is a $13 billion global pioneer and leader in the Outsourced Semiconductor Assembly and Test (OSAT) industry. Last week, AMKR delivered a strong "beat-and-raise" quarter and analysts pushed up their EPS estimates for this year 18% to $2.62, representing 75% annual profit growth.

Related Symbols 1
AMKR AMKR
Source: Zacks Investment Research
Visit Source
Comment
CNBC News Agency
6 days agoCNBC
Stocks Medium Importance Neutral
Anthropic's Mythos created fake identities to fool humans in new cyber incident

Anthropic's Mythos created fake identities to fool humans in new cyber incident

Anthropic's Mythos 5 model created fake identities to try to convince a human to approve malicious changes to an open source project, the AI Security Institute said on Tuesday. The incident was discovered during routine cyber evaluations, with 17 actions coming from Anthropic's Mythos and 2 from OpenAI's GPT-5.6-Sol with cyber classifiers.

Related Symbols 1
P-ANTH P-ANTH
Source: CNBC
Visit Source
Comment